Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection

Blood

Volumn 96, Issue 13, 2000, Pages 4091-4095

  Sidenius, Nicolai ^a   Sier, Cornells F M ^b   Ullum, Henrik ^b   Pedersen, Benle Klarlund ^b   Lepri, Alessandro Cozzi ^b   Blasi, Francesco ^b   Eugen Olsen, Jesper ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; DENMARK; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE TABLE; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SOLUBILITY; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DENMARK; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOLUBILITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034672145     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol. 1997;9:714-724.
2. Blasi F. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol Today. 1997;18:415-417.
3. Plesner T, Behrendt N, Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells. 1997;15:398-408.
4. Gyetko MR, Chen GH, McDonald RA, et al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J Clin Invest. 1996;97: 1818-1826.
5. May AE, Kanse SM, Lund LR, Gisler RH, Imhof BA, Preissner KT. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J Exp Med. 1998:188:1029-1037.
6. Gyetko MR, Libre EA, Fuller JA, Chen G-H, Toews GB. Urokinase is required for T lymphocyte proliferation and activation in vitro. J Lab Clin Med. 1999:133:274-288.
7. Sier CFM, Stephens RW, Bizik J, et al. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res. 1998:58:1843-1849.
8. Stephens RW, Nielsen HJ, Christensen IJ, et al. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst. 1999:91:869-874.
9. Pedersen N, Schmitt M, Ronne E, et al. A ligandfree, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer. J Clin Invest. 1993:92:2160-2167.
10. Holst-Hansen C, Hamers MJ, Johannessen BE, Brünner N, Stephens RW. Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies. Br J Cancer. 1999:81:203-211.
11. Dana K, Andreasen PA, Grondahl Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985:44:139-266.
12. Nykjaer A, Moller B, Todd RF. et al. Urokinase receptor: an activation antigen in human T lymphocytes. J Immunol. 1994:152:505-516.
13. Frank I, Stoiber H, Godar S, et al. Acquisition of host cell-surface-derived molecules by HIV-1. AIDS. 1996:10:1611-1620.
14. Speth C, Pichler I, Stōckl G, Mair M, Dierich MP. Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection. Immunobiology. 1998;199:152-162.
15. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, Pedersen BK. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med. 1995:182:789-799.